The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12429862.
- Also identified by PMC identifier 137771.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The breast cancer resistance protein (BCRPABCG2) is a member of the ATP-binding cassette family of drug transporters and confers resistance to various anticancer drugs. We show here that mice lacking Bcrp1Abcg2 become extremely sensitive to the dietary chlorophyll-breakdown product pheophorbide a, resulting in severe, sometimes lethal phototoxic lesions on light-exposed skin. Pheophorbide a occurs in various plant-derived foods and food supplements. Bcrp1 transports pheophorbide a and is highly efficient in limiting its uptake from ingested food. Bcrp1(-/-) mice also displayed a previously unknown type of protoporphyria. Erythrocyte levels of the heme precursor and phototoxin protoporphyrin IX, which is structurally related to pheophorbide a, were increased 10-fold. Transplantation with wild-type bone marrow cured the protoporphyria and reduced the phototoxin sensitivity of Bcrp1(-/-) mice. These results indicate that humans or animals with low or absent BCRP activity may be at increased risk for developing protoporphyria and diet-dependent phototoxicity and provide a striking illustration of the importance of drug transporters in protection from toxicity of normal food constituents.
Medical subject headings
- ATP-Binding Cassette Transporters
- Chlorophyll
- Dermatitis, Phototoxic
- Drug Resistance
- Neoplasm Proteins
- Photosensitizing Agents
- Porphyria, Hepatoerythropoietic
- Porphyrins
- Protoporphyrins